Fig. 3From: Recent advances in exosome-mediated nucleic acid delivery for cancer therapyA Engineered exosomes to deliver ASO to produce effective antitumor activity [70]. B Exosomes loaded with CRISPR/Cas9 targeting PARP-1 for cancer therapy [71]. C The hybrid exosomes successfully deliver CRISPR/dCas9 interference system [63]Back to article page